First Bank & Trust Biogen Inc. Transaction History

First Bank & Trust

$510 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$222.59 - $267.94 $12,687 - $15,272	-57 Reduced 6.78%	784 $202,000
Q3 2023 Oct 11, 2023	BUY	$253.3 - $285.89 $4,052 - $4,574	16 Added 1.94%	841 $216,000
Q2 2023 Jul 12, 2023	SELL	$275.25 - $318.06 $6,055 - $6,997	-22 Reduced 2.6%	825 $235,000
Q1 2023 Apr 25, 2023	SELL	$256.56 - $292.34 $256 - $292	-1 Reduced 0.12%	847 $235,000
Q4 2022 Jan 27, 2023	BUY	$252.44 - $306.72 $2,776 - $3,373	11 Added 1.31%	848 $235,000
Q2 2022 Jul 22, 2022	BUY	$187.54 - $223.02 $14,253 - $16,949	76 Added 9.99%	837 $170,000
Q1 2022 Apr 29, 2022	BUY	$193.77 - $244.14 $9,494 - $11,962	49 Added 6.88%	761 $161,000
Q4 2021 Feb 01, 2022	SELL	$223.92 - $287.77 $38,066 - $48,920	-170 Reduced 19.27%	712 $171,000
Q3 2021 Oct 18, 2021	SELL	$282.99 - $369.05 $3,395 - $4,428	-12 Reduced 1.34%	882 $250,000
Q1 2021 Apr 14, 2021	SELL	$242.95 - $284.63 $12,390 - $14,516	-51 Reduced 5.4%	894 $250,000
Q4 2020 Jan 27, 2021	SELL	$236.26 - $355.63 $30,241 - $45,520	-128 Reduced 11.93%	945 $231,000
Q3 2020 Oct 26, 2020	SELL	$264.77 - $305.71 $6,089 - $7,031	-23 Reduced 2.1%	1,073 $304,000
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $1,810 - $2,397	-7 Reduced 0.63%	1,096 $293,000
Q1 2020 Apr 14, 2020	BUY	$268.85 - $341.04 $28,498 - $36,150	106 Added 10.63%	1,103 $349,000
Q4 2019 Jan 31, 2020	BUY	$220.06 - $304.07 $440 - $608	2 Added 0.2%	997 $296,000
Q3 2019 Oct 17, 2019	BUY	$217.44 - $243.88 $96,760 - $108,526	445 Added 80.91%	995 $232,000
Q2 2019 Jul 26, 2019	BUY	$219.29 - $241.72 $33,112 - $36,499	151 Added 37.84%	550 $129,000
Q1 2019 Apr 15, 2019	BUY	$216.71 - $338.96 $86,467 - $135,245	399 New	399 $94,000

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First Bank & Trust with notifications on news.

Account